Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease
Santé animale
Téléchargement 6.72 MoAuteurs
Søren Saxmose Nielsen [3]; Julio Alvarez [4]; Dominique Joseph Bicout [5]; Paolo Calistri [6]; Elisabetta Canali [7]; Julian Ashley Drewe [8]; Bruno Garin‐Bastuji [9]; José Luis Gonzalez Rojas [10]; Christian Gortázar Schmidt [11]; Mette Herskin [12]; Virginie Michel [13]; Miguel Ángel Miranda Chueca [14]; Barbara Padalino [15]; Paolo Pasquali [16]; Liisa Helena Sihvonen [17]; Hans Spoolder [18]; Ståhl, Karl [19]; Antonio Velarde [20]; Arvo Viltrop [21]; Christoph Winckler [22]; Kris De Clercq [23]; Gubbins, Simon [24]; Klement, Eyal [25]; Jan Arend Stegeman [26]; Sotiria‐Eleni Antoniou [27]; Inma Aznar [28]; Alessandro Broglia [29]; Yves Van der Stede [30]; Gabriele Zancanaro [31]; Helen Clare Roberts [32]Mots-clés
Résumé:
EFSA received a mandate from the EC to assess the effectiveness of some of the control measuresagainst diseases included in the Category A list according to Regulation (EU) 2016/429 ontransmissible animal diseases (‘Animal Health Law’). This opinion belongs to a series of opinions wherethese control measures are assessed, with this opinion covering the assessment of control measuresfor Lumpy Skin Disease (LSD). In this opinion, EFSA and the AHAW Panel of experts review theeffectiveness of: i) clinical and laboratory sampling procedures, ii) monitoring period and iii) theminimum radius of th…